Skip to main
HQL

HQL Market Capitalization Overview

Market Cap: $484.20M as of Jan 8, 2026

$484.20M
$9.53M (1.93%)past month
As of Jan 8, 2026, HQL has a market capitalization of $484.20M. Over the past 30 days, its market cap has decreased by -3.01%, while in the last 12 months, it has decreased by -0.06%.

Market capitalization represents the total value of abrdn Life Sciences Investors as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

HQL Market Cap Formula = Stock Price * Shares Outstanding

The market cap of HQL helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

HQL Market Cap History

DateMarket CapChange
Dec 1, 2025$499.21M+1.11%
Nov 3, 2025$493.72M+8.50%
Oct 1, 2025$455.03M+12.09%
Sep 2, 2025$405.95M+7.16%
Aug 1, 2025$378.81M+1.63%
Jul 1, 2025$372.75M+4.87%
Jun 2, 2025$355.42M-3.07%
May 1, 2025$366.68M+8.64%
Apr 1, 2025$337.51M-6.94%
Mar 3, 2025$362.67M-5.42%
Feb 3, 2025$383.46M+5.97%
Jan 2, 2025$361.85M-7.42%

HQL End of Year Market Cap History

DateMarket CapChange
2026$484.20M-0.06%
2025$484.48M+35.01%
2024$358.84M+1.71%
2023$352.82M-1.25%
2022$357.30M-23.47%
2021$466.90M

FAQs About abrdn Life Sciences Investors (HQL) Market Cap

As of Jan 8, 2026, the market capitalization of HQL is $484.20M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, abrdn Life Sciences Investors ’s market capitalization has decreased by -1.93%, changing from $493.72M to $484.20M as of Jan 8, 2026.

In the last 3 months, abrdn Life Sciences Investors ’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, abrdn Life Sciences Investors ’s market capitalization increased from $358.84M in January to $484.48M in December, reflecting a 35.01% change.

In the past five years, HQL has had a compound annual growth rate (CAGR) of 0.74% in market capitalization. This means its market cap has grown at an average rate of 0.74% per year.

abrdn Life Sciences Investors (HQL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.